We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Gluten-free Bakers Have Some Time To Worry About Celiac Disease Vaccine

October 22, 2012: 12:00 AM EST
American biotech  company ImmusanT has developed a celiac disease vaccine that is undergoing clinical testing in New Zealand, Australia and the U.S. With the gluten-free market likely to be worth as much as US$375.5 million within a couple of years, are bakers who produce gluten-free products feeling threatened by the advancement? Not yet, they say. Availability of the novel vaccine – Nexvax2 would reduce the immune system’s adverse response to gluten – is still 10 to 15 years away.
Georgi Gyton, "Could vaccine threaten gluten-free bakery?", Bakery Info, October 22, 2012, © William Reed Business Media Ltd
Cereals & Bakery
United Kingdom
Companies, Organizations
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.